Table 3.
Spearman’s rho correlation of palliative response with patient and clinical factors Palliation achieved? (0=no, 1=yes)
| n | Correlation Coefficient |
Sig. (2- tailed) |
|
|---|---|---|---|
| Age (years) | 75 | 0.10 | 0.383 |
| KPS | 75 | −0.10 | 0.414 |
| Histology (SCC, salivary, thyroid, sarcoma, other) |
75 | −0.17 | 0.141 |
| T1-2 vs T3-4 | 65 | −0.03 | 0.834 |
| N0-1 vs N2-3 | 75 | 0.01 | .952 |
| Prior RT to treated site | 75 | −0.03 | 0.77 |
| Surgery to primary site | 75 | −0.13 | 0.287 |
| Chemotherapy as part of palliative treatment |
75 | 0.15 | 0.187 |
| Chemotherapy concurrently with at least 1 cycle of RTOG 8502 |
75 | 0.04 | 0.743 |
| Additional palliative RT to primary site | 72 | −0.03 | 0.836 |
| Cycles of RTOG 8502 | 75 | 0.29 | 0.012a |
p<=0.05
Abbreviations: KPS, Karnofsky Performance Status; RT, radiotherapy; RTOG, Radiation Therapy Oncology Group;